Research Article

In silico analysis of pulmonary arterial hypertension to identify key biomarkers at protein and RNA levels

Volume: 11 Number: 4 October 24, 2023
TR EN

In silico analysis of pulmonary arterial hypertension to identify key biomarkers at protein and RNA levels

Abstract

Pulmonary arterial hypertension (PAH) is a chronic cardiopulmonary disorder marked by a raised hypertension in the pulmonary arteries. There is no remedy for PAH, existing medications can help reduce the disease’s progression. This research aimed to investigate potential protein and RNA biomarkers of PAH by bioinformatic analysis. Two PAH datasets accessed from the publicly available Gene Expression Omnibus (GEO) database were used to discover differentially expressed genes (DEGs). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses for common DEGs were conducted by the DAVID tool. Cytoscape was used to create the protein-protein interaction (PPI) and pick the top 10 hub genes. The transcription factors (TFs) and microRNAs (miRNAs) that target DEGs and hub genes were investigated using the JASPAR database. Potential therapeutics that target the top hub genes have been discovered. Ten hub genes were discovered to be linked to the pathogenesis of PAH (CCL5, TLR4, TLR1, SPP1, CYBB, HGF, IGF1, SELL, CD163, and POSTN). “Positive regulation of tumor necrosis factor biosynthetic process” and a “toll-like receptor signaling pathway” are the most enriched GO term and KEGG pathway, respectively. “hsa-mir-26b-5p, hsa-mir-146a-5p, hsa-mir-335-5p” and FOXC1, YY1, GATA2 are the top TFs targeting hub genes. 21 drugs targeting ten hub genes have been discovered. Our results would help to discover the pathogenesis of PAH and hub genes, miRNAs and 10 TFs that might serve as potential therapeutic targets at protein and RNA levels for PAH patients.

Keywords

Pulmonary arterial hypertension, Biomarkers, Transcription factors, MicroRNAs, Differentially expressed genes

References

  1. [1] Tuder RM, Archer SL, Dorfmuller P, Erzurum SC, Guignabert C, Michelakis E, Rabinovitch M, Schermuly R, Stenmark KR, Morrell NW, “Relevant issues in the pathology and pathobiology of pulmonary hypertension, ” J Am Coll Cardiol, 62(25 Suppl):D4–12, 2013.
  2. [2] Simonneau G, Montani D, Celermajer DS, et al., “Haemodynamic definitions and updated clinical classification of pulmonary hypertension, ” Eur Respir, 53(1), 2019.
  3. [3] Edgar R, Domrachev M, Lash AE., Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res, 30(1):207-10, 2002.
  4. [4] Mi, , Muruganujan, A, and Thomas, P, “PANTHER in Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees,” Nucleic Acids Res,. 41(Database issue), D377-386, 2013. [5] Huang DW, Sherman BT, Lempicki RA, “Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resource,” Nature Protoc, 4(1):44-57, 2009.
  5. [6] Warde-Farley, D, Donaldson, S. L, Comes, O, Zuberi, K, Badrawi, R, Chao, P, Franz, M, Grouios, C, Kazi, F, F, Lopes, C T, Maitland, A, Mostafavi, S, Montojo, J, Shao, Q, Wright, G, Bader, G D, & Morris, Q, “The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function,” Nucleic acids research 38(Web Server issue), W214–W220, 2010.
  6. [7] Xia, J, Gill, E E, and Hancock, R E, “NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data,” Nat. Protoc, 10,823–844, 2015.
  7. [8] Khan, A, Fornes, O, Stigliani, A, Gheorghe, M, Castro-Mondragon, J A, Van Der Lee, R, et al., “JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework,” Nucleic Acids Res, 46, D260–D266, 2018.
  8. [9] Sheng-Da Hsu, Feng-Mao Lin, Wei-Yun Wu, Chao Liang, Wei-Chih Huang, Wen-Ling Chan, Wen-Ting Tsai, Goun-Zhou Chen, Chia-Jung Lee, Chih-Min Chiu, Chia-Hung Chien, Ming-Chia Wu, Chi-Ying Huang, Ann-Ping Tsou, Hsien-Da Huang, “ miRTarBase: a database curates experimentally validated microRNA–target interactions,” Nucleic Acids Research Volume, 39, Issue suppl_1, Pages D163–D169, 2011.
  9. [10] Xia J, Gill EE, Hancock RE., “NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data,” Nat Protoc, 10(6):823-44, 2015.
  10. [11] Cotto, K C, Wagner, A H, Feng, Y Y, Kiwala, S, Coffman, A C, Spies G, Wollam, A, Spies, N C, Griffith, O L, & Griffith, M, “DGIdb 3.0: a redesign and expansion of the drug-gene interaction database,” Nucleic acids research 46(D1), D1068–D1073, 2018.
APA
Akçay, S. (2023). In silico analysis of pulmonary arterial hypertension to identify key biomarkers at protein and RNA levels. Duzce University Journal of Science and Technology, 11(4), 2053-2067. https://doi.org/10.29130/dubited.1103902
AMA
1.Akçay S. In silico analysis of pulmonary arterial hypertension to identify key biomarkers at protein and RNA levels. DUBİTED. 2023;11(4):2053-2067. doi:10.29130/dubited.1103902
Chicago
Akçay, Sevinç. 2023. “In Silico Analysis of Pulmonary Arterial Hypertension to Identify Key Biomarkers at Protein and RNA Levels”. Duzce University Journal of Science and Technology 11 (4): 2053-67. https://doi.org/10.29130/dubited.1103902.
EndNote
Akçay S (October 1, 2023) In silico analysis of pulmonary arterial hypertension to identify key biomarkers at protein and RNA levels. Duzce University Journal of Science and Technology 11 4 2053–2067.
IEEE
[1]S. Akçay, “In silico analysis of pulmonary arterial hypertension to identify key biomarkers at protein and RNA levels”, DUBİTED, vol. 11, no. 4, pp. 2053–2067, Oct. 2023, doi: 10.29130/dubited.1103902.
ISNAD
Akçay, Sevinç. “In Silico Analysis of Pulmonary Arterial Hypertension to Identify Key Biomarkers at Protein and RNA Levels”. Duzce University Journal of Science and Technology 11/4 (October 1, 2023): 2053-2067. https://doi.org/10.29130/dubited.1103902.
JAMA
1.Akçay S. In silico analysis of pulmonary arterial hypertension to identify key biomarkers at protein and RNA levels. DUBİTED. 2023;11:2053–2067.
MLA
Akçay, Sevinç. “In Silico Analysis of Pulmonary Arterial Hypertension to Identify Key Biomarkers at Protein and RNA Levels”. Duzce University Journal of Science and Technology, vol. 11, no. 4, Oct. 2023, pp. 2053-67, doi:10.29130/dubited.1103902.
Vancouver
1.Sevinç Akçay. In silico analysis of pulmonary arterial hypertension to identify key biomarkers at protein and RNA levels. DUBİTED. 2023 Oct. 1;11(4):2053-67. doi:10.29130/dubited.1103902